Regulatory

• 6 Nov, 2024
  Spago Nanomedical delårsrapport januari-september 2024
• 6 Nov, 2024
  Spago Nanomedical interim report January-September 2024
• 1 Oct, 2024
  Spago Nanomedical i ny fas med fullt fokus på Tumorad-programmet
• 1 Oct, 2024
  Spago Nanomedical in new phase with full focus on the Tumorad program
• 21 Aug, 2024
  Spago Nanomedical interim report January-June 2024
• 21 Aug, 2024
  Spago Nanomedical delårsrapport januari-juni 2024
• 10 Jun, 2024
  Kommuniké från årsstämma 2024 i Spago Nanomedical AB
• 10 Jun, 2024
  Bulletin from the 2024 Annual General Meeting of Spago Nanomedical AB
• 31 May, 2024
  Spago Nanomedical announces outcome of the exercise of warrants series TO12
• 31 May, 2024
  Spago Nanomedical offentliggör utfall av nyttjande av teckningsoptioner serie TO12